Literature DB >> 1654885

Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.

A el Battari1, P Forget, F Fouchier, P Pic.   

Abstract

We used inhibitors of four steps of the glycosylation pathway to examine the contribution of carbohydrate moieties to the ligand-binding activity, cell-surface expression and apparent molecular mass of the human vasoactive intestinal peptide (VIP) receptor. Human melanoma IGR 39 cells, incubated for 60 h with the inhibitors tunicamycin, castanospermine, swainsonine or deoxymannojirimycin, under conditions where cell viability and protein synthesis were not affected, expressed VIP receptor species with different VIP-binding properties. The most pronounced effects on VIP binding were obtained with tunicamycin and deoxymannojirimycin, which respectively caused 80% and 67% inhibition. Treatment with either swainsonine or castanospermine resulted in only a 25-32% decrease in VIP specific binding. Based on Scatchard analyses of data from competition experiments, the decrease in VIP-binding activity in either swainsonine- or deoxymannojirimycin-treated cells was due to a decrease in ligand affinity; the cell-surface number of VIP-binding sites remained unchanged. In contrast, tunicamycin and castanospermine caused decreases in the cell-surface number of functional VIP receptors without affecting affinity. Besides, the drug-treated cells produced VIP-binding proteins with different molecular masses and endoglycosidase H (Endo H) sensitivities. When compared with their counterpart synthesized in control cells, VIP-binding proteins produced by deoxymannojirimycin- or swainsonine-treated cells were smaller in size and exhibited the expected sensitivity to Endo H. No modification in the apparent molecular mass was observed in the presence of either castanospermine or tunicamycin. In addition, after Endo F digestion, all of the deglycosylated proteins migrated with the same electrophoretic mobility. Finally, processing in the presence of castanospermine led to an Endo H-resistant receptor species which showed an unexpected neuraminidase-sensitivity, indicating that, as in control cells, these receptors carry V-linked oligosaccharides with terminal sialic acid residues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654885      PMCID: PMC1151377          DOI: 10.1042/bj2780527

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function.

Authors:  T S Olson; M J Bamberger; M D Lane
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

2.  N-glycosylation in expression and function of beta-adrenergic receptors.

Authors:  S T George; A E Ruoho; C C Malbon
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

3.  Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.

Authors:  J M Martin; H Darbon; J Luis; A el Battari; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

4.  Role of glycosylation for beta 2-adrenoceptor function in A431 cells.

Authors:  F Boege; M Ward; R Jürss; M Hekman; E J Helmreich
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

Review 5.  The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.

Authors:  J Luis; J M Martin; A el Battari; J Marvaldi; J Pichon
Journal:  Biochimie       Date:  1988-10       Impact factor: 4.079

6.  A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.

Authors:  J M Martin; J Luis; J Marvaldi; J Pichon; P Pic
Journal:  Eur J Biochem       Date:  1989-03-15

7.  Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.

Authors:  M Svoboda; P De Neef; M Tastenoy; J Christophe
Journal:  Eur J Biochem       Date:  1988-10-01

Review 8.  HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.

Authors:  G Marchis-Mouren; J M Martin; J Luis; A el Battari; J M Muller; J Marvaldi; J Pichon
Journal:  Biochimie       Date:  1988-05       Impact factor: 4.079

9.  Synthesis of epidermal growth factor receptor in human A431 cells. Glycosylation-dependent acquisition of ligand binding activity occurs post-translationally in the endoplasmic reticulum.

Authors:  L J Slieker; T M Martensen; M D Lane
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

10.  Assembly of asparagine-linked oligosaccharides in baby hamster kidney cells treated with castanospermine, an inhibitor of processing glucosidases.

Authors:  L Foddy; R C Hughes
Journal:  Eur J Biochem       Date:  1988-08-01
View more
  3 in total

1.  Asn54-linked glycan is critical for functional folding of intercellular adhesion molecule-5.

Authors:  Tomohiro Ohgomori; Tomohisa Nanao; Akinori Morita; Masahiko Ikekita
Journal:  Glycoconj J       Date:  2011-12-21       Impact factor: 2.916

2.  Significance of the carbohydrate moiety of the rat ovarian luteinizing-hormone/chorionic-gonadotropin receptor for ligand-binding specificity and signal transduction.

Authors:  U E Petäjä-Repo; W E Merz; H J Rajaniemi
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

3.  Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells.

Authors:  G Servant; D T Dudley; E Escher; G Guillemette
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.